Skip to main content
Incanthera plc logo

Incanthera plc — Investor Relations & Filings

Ticker · INC ISIN · GB00BGL7YW15 LEI · 2138002HEV4UFBOEXQ97 Aquis Stock Exchange Manufacturing
Open in API
Filings indexed 97 across all filing types
Latest filing 2025-06-02 Regulatory Filings
Country GB United Kingdom
Listing Aquis Stock Exchange INC

About Incanthera plc

https://incanthera.com/

Incanthera plc is a therapeutics company specializing in the discovery and development of targeted solutions for dermatology and oncology. The company develops and applies sophisticated formulation and delivery technologies to create novel treatments. Its pipeline includes clinical-stage oncology assets intended for licensing to pharmaceutical partners. Incanthera has also commercialized its dermatological expertise through its direct-to-consumer skincare brand, Skin+CELL, which is designed to address unmet needs in the skincare market.

Recent filings

Filing Released Lang Actions
Direct To Customer Agency Agreement Completed
Regulatory Filings Classification · 100% confidence The document is a regulatory announcement (RNS) issued by Incanthera plc regarding the completion of a business agreement with a marketing agency for its 'Skin + CELL' product line. It does not fit into specific categories like financial reports, board changes, or dividend announcements. As it is a general corporate update disseminated via a Regulatory Information Service (RNS), it falls under the 'Regulatory Filings' category.
2025-06-02 English
Commercial Update
Regulatory Filings Classification · 98% confidence The document is a regulatory announcement (RNS) issued by Incanthera PLC regarding a commercial update on their 'Skin + CELL' product line. It details a change in partnership strategy, moving from a retail partnership to a direct-to-consumer (DTC) model. As this is a general corporate update regarding business operations and strategy, and does not fit into specific categories like financial results (ER/IR), board changes (MANG), or share transactions (POS/SHA), it falls under the 'Regulatory Filings' (RNS) category as the appropriate fallback for general corporate announcements.
2025-05-22 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings'. It explicitly details a change in shareholding percentage by Unicorn Asset Management Limited in Incanthera PLC, crossing a reporting threshold. This fits the definition of a Major Shareholding Notification (MRQ).
2025-04-08 English
Warrant Extension, Debt Conversion & Equity Issue
Regulatory Filings Classification · 98% confidence The document is an official regulatory announcement from Incanthera plc regarding the extension of warrants, debt conversion, and the issuance of new equity shares. It details the specific number of shares being issued, the impact on total voting rights, and the related party transaction implications. While it involves share issuance, it is a comprehensive announcement of corporate actions rather than just a simple notice of a report publication. It fits best under 'Share Issue/Capital Change' as it describes the conversion of debt into equity and the resulting change in capital structure.
2025-04-01 English
Commercial Update
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' RNS filings are general regulatory announcements. The content is a 'Commercial Update' regarding product focus and termination of an agreement, which is a typical corporate announcement disseminated via RNS. Since it is not a full annual report (10-K), a detailed interim report (IR), an earnings release (ER), or a specific proxy/governance document, the most appropriate general regulatory category is RNS.
2025-03-28 English
Resolution of Allegations of Patent Infringement
Legal Proceedings Report Classification · 99% confidence The document begins with an 'RNS Number' and is dated March 25, 2025. It contains language typical of a regulatory announcement, such as 'This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation' and concludes with boilerplate text from 'RNS, the news service of the London Stock Exchange.' The content announces the 'Successful Resolution of Allegations of Patent Infringement' and states the company 'will update the market further on these discussions in due course.' This structure—a brief, material update disseminated via an official news service (RNS) that references inside information—strongly indicates a general regulatory announcement rather than a comprehensive report (like 10-K or IR) or a specific event material (like AGM or CT). Since it is a general regulatory announcement that doesn't fit the highly specific categories like DIRS, DIV, or CAP, the most appropriate fallback category is Regulatory Filings (RNS). The document length is substantial (6912 chars), but the content is purely an announcement of a legal resolution, not the full legal document itself.
2025-03-25 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.